Abstracts

Abstract submission deadline: December 2nd, 2024

 

ABSTRACT SUBMISSION

Abstracts can only be submitted through the Congress website and no later than December 2nd, 2024. Abstracts received by e-mail will not be considered. Should you have any problems in submitting an abstract online, please contact the Organizing Secretariat at rheumapreg2025@aimgroup.eu.

 

ABSTRACT NOTIFICATION

Once the abstract is submitted, a confirmation email will be sent to the registered author’s e-mail address provided in the ‘Personal Details’ section.

Notification of abstract acceptance will be sent via email by December 18th, 2024.

The registered author is responsible for sharing the outcome of the abstract examination and any other related information with their co-authors.

Please note that the presenting author of the accepted abstract must be registered to attend the Congress.

 

ABSTRACT REQUIREMENTS

When you submit the abstract, please indicate your preferred method of presentation (poster or oral communication) and select the category that best describes the content of your paper.

 

Topics: 

  • Immunosuppressive therapy of rheumatic diseases during pregnancy and lactation
  • Management of Rheumatoid Arthritis, Psoriatic Arthritis, Axial Spondyloarthritis, and Juvenile Idiopathic Arthritis during Pregnancy
  • Pregnancy with Lupus
  • Antiphospholipid Syndrome: from understanding to evolving management
  • Myositis, Scleroderma, Sjögren’s and Vasculitis in pregnancy
  • Revisiting Osteoporosis in reproductive years
  • Recurrent Pregnancy loss and the role of IVIG therapy: myth and evidence
  • From placenta pathology to adverse obstetric outcome: mechanisms and management (Preeclampsia, FGR, Placental insufficiency)
  • Challenges of fertility in context of rheumatic disease and social changes
  • Artificial reproductive techniques and the role of fertility preservation in rheumatic diseases
  • Update on the registries
  • Gender medicine
  • Navigating Teratogenic Terrain: contraception and management of unintended pregnancy
  • Patient perspectives: family planning with rheumatic diseases, the essential role of teamwork
  • Paternal rheumatic disease and medication- influence on family planning
  • Supporting new mothers with rheumatic diseases: post-partum challenges
  • Long-term follow up of children

Keywords: please report 3 keywords

 

The maximum size of abstracts is limited to 3.200 characters (approx. 350 words) including spaces.

Structured abstracts are mandatory. The abstracts should state clearly:

• Purpose

• Methods

• Results

• Conclusions

Tables, charts or other graphics could be included as well as one image in jpeg format.

It is the author’s responsibility to submit a correct abstract; any errors in spelling, grammar or scientific fact will be reproduced as typed by the author, if accepted.

Please follow carefully the instructions reported on the online pages and fill in all the requested fields, in order to guarantee a correct and complete publication of the text.

Changes to the abstracts can only be accepted until the deadline and can be added in the text using the User ID and Password received when submitting.

 

INFORMATION FOR PRESENTERS

Oral Presentations
The selected presenting authors are requested to upload their presentation (landscape format 16:9) on a USB drive or laptop and deliver it to the slide center room at least one hour before the beginning of the session.

Posters
All posters must have maximum dimensions of 70 x 100 cm (portrait format).

Please note that poster boards will be set up in a reserved area of the Congress venue and must remain up throughout the Congress, so that participants will be able to view them at their convenience.